GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹256 Cr | ₹230 Cr | ₹132 Cr | ₹68 Cr | ₹59 Cr |
What is the latest Total Liabilities ratio of GENNEX LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹256 Cr |
| Mar2024 | ₹230 Cr |
| Mar2023 | ₹132 Cr |
| Mar2022 | ₹68 Cr |
| Mar2021 | ₹59 Cr |
How is Total Liabilities of GENNEX LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹256 Cr | 11.36 | |
| Mar2024 | ₹230 Cr | 73.82 | |
| Mar2023 | ₹132 Cr | 94.30 | |
| Mar2022 | ₹68 Cr | 15.49 | |
| Mar2021 | ₹59 Cr | - | |
Compare Total Liabilities of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹327.4 Cr | -2.8% | -18.5% | -27.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹439,378.0 Cr | 2.8% | 6.7% | 2.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,996.0 Cr | 1.9% | -0.5% | 6.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,959.0 Cr | 0.1% | 3.4% | 15.8% | Stock Analytics | |
| CIPLA | ₹123,666.0 Cr | 1.8% | -3.2% | 2.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,008.0 Cr | 2.7% | 0.4% | 3.4% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | -2.8% |
-18.5% |
-27.6% |
| SENSEX | 0.6% |
1.3% |
7% |
You may also like the below Video Courses